Smoking and cognitive function in Parkinson's disease

被引:19
|
作者
Weisskopf, Marc G.
Grodstein, Francine
Ascherio, Alberto
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Channing Lab, Dept Med,Brigham & Womens Hosp, Boston, MA USA
[4] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
关键词
Parkinson's disease; cognitive function; smoking; prospective studies; epidemiology; risk factors;
D O I
10.1002/mds.21373
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The risk of dementia among Parkinson's disease (PD) patients is greatly elevated compared to controls, yet little is known about determinants of cognitive function among PD patients. We assessed the relation between cigarette smoking prior to disease onset and later cognitive function among PD patients (n = 286) and age- and sex-matched controls (n = 1144) participating in the Nurses' Health Study and Health Professionals Follow-up Study. Both groups completed telephone-administered assessments of cognitive function. We used linear regression to calculate mean differences in cognitive test scores across smoking categories, adjusted for age, education, sex, age at onset of PD, and years since diagnosis. PD patients scored significantly worse on all tests than their matched controls. In analyses only among PD cases, but not among controls, current smokers at PD onset scored worse than never smokers on the Telephone Interview for Cognitive Status (difference = -0.82, 95% CI: -1.33, -0.30, P = 0.002) as well as on a global score combining results of all tests (difference = -0.36, 95% Cl: -0.72, 0.01, P = 0.06). This difference was equivalent to the difference in global score observed among controls similar to 10 years apart in age. Analyses of pack-years of smoking prior to disease onset gave similar results. These findings, nested in prospective cohort studies, suggest that cigarette smoking prior to disease onset is associated with worse cognitive function in PD. (c) 2007 Movement Disorder Society.
引用
收藏
页码:660 / 665
页数:6
相关论文
共 50 条
  • [41] Tau pathology is associated to cognitive and not motor function in Parkinson's disease
    Liepelt-Scarfone, I.
    Vanderstichele, H.
    Maetzler, W.
    Francois, C.
    Schulte, C.
    Timmers, M.
    Van Nueten, L.
    Salvadore, G.
    Brockmann, K.
    Gasser, T.
    Streffer, J.
    Stoops, E.
    Berg, D.
    MOVEMENT DISORDERS, 2019, 34 : S696 - S697
  • [42] The effect of sleep and wakefulness disorders on cognitive function in Parkinson's disease
    Matmurodov, R. J.
    Turgunkhujaev, O. E. U.
    Khalimova, K. M.
    Ergashev, U. S.
    MOVEMENT DISORDERS, 2015, 30 : S170 - S170
  • [43] Pimvanserin (Nuplazid) Effect on Cognitive Function in Parkinson's Disease Psychosis
    Starr, James
    Grenier, Rachel
    Altshuler, Marcelle
    Kimbason, Tara
    Mundel, Elizabeth
    Yusuf, Nadia
    Lawler, Abigail
    Torres-Yaghi, Yasar
    Moussa, Charbel
    Pagan, Fernando
    MOVEMENT DISORDERS, 2018, 33 : S41 - S41
  • [44] Action Verb Generation as a marker of cognitive function in Parkinson's disease
    Yerokhin, O.
    Smith, K.
    MOVEMENT DISORDERS, 2017, 32
  • [45] Effect of education level on cognitive function in patients with Parkinson's disease
    武冬冬
    China Medical Abstracts (Internal Medicine), 2019, (04) : 234 - 235
  • [46] Serum uric acid levels and cognitive function in Parkinson's disease
    DiFrancisco-Donoghue, J.
    Werner, W.
    Krishnamachari, B.
    Arabian, K.
    Thomas, E.
    Granger, D.
    Gallagher, R.
    MOVEMENT DISORDERS, 2019, 34 : S338 - S338
  • [47] Multi-Modal Hallucinations and Cognitive Function in Parkinson's Disease
    Katzen, Heather
    Myerson, Connie
    Papapetropoulos, Spiridon
    Nahab, Fatta
    Gallo, Bruno
    Levin, Bonnie
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2010, 30 (01) : 51 - 56
  • [48] Impact of Acute Dopamine Replacement on Cognitive Function in Parkinson's Disease
    Seemiller, Joseph
    Morrow, Christopher
    Hinkle, Jared T.
    Perepezko, Kate
    Kamath, Vidyulata
    Pontone, Gregory M.
    Mills, Kelly A.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (05): : 534 - 542
  • [49] Effects of apomorphine on neuropsychiatric and cognitive function in patients with Parkinson's disease
    Postma, A. -G.
    Drent, M.
    van Laar, T.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S113 - S113
  • [50] French consensus procedure for assessing cognitive function in Parkinson's disease
    Dujardin, K.
    Auzou, N.
    Lhommee, E.
    Czernecki, V.
    Dubois, B.
    Fradet, A.
    Maltete, D.
    Meyer, M.
    Pineau, F.
    Schmitt, E.
    Sellal, F.
    Tison, F.
    Vidal, T.
    Azulay, J. -P.
    Welter, M. -L.
    Corvol, J. -C.
    Durif, F.
    Rascol, O.
    REVUE NEUROLOGIQUE, 2016, 172 (11) : 696 - 702